-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines plans USD 250 million convertible senior notes offering due 2033

PUBT·04/13/2026 20:03:07
Listen to the news
Revolution Medicines plans USD 250 million convertible senior notes offering due 2033
  • Revolution Medicines launched public offering of USD 250 million convertible senior notes due 2033.
  • Notes will be senior unsecured obligations, maturing May 1, 2033.
  • Issuer expects to grant 30-day option for underwriters to buy up to additional USD 37.5 million principal amount to cover over-allotments.
  • Redemption option starts May 6, 2030, subject to stock price exceeding 130% of conversion price for specified period.
  • Net proceeds earmarked for general corporate purposes, including R&D, potential commercialization, operating expenses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief on April 13, 2026, and is solely responsible for the information contained therein.